Gilead Sciences Inc

Healthcare · Drug Manufacturers - General

150.10$ -0.5% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Gilead Sciences Inc (GILD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 49,362 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet GILD
Line item	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	62,373	62,125	56,292	53,579	54,525	58,995	56,434	55,721	58,533	59,023	56,278	49,362
Current Assets	15,980	16,085	14,041	12,317	14,779	19,173	16,901	14,718	17,874	18,342	18,641	13,945
Cash	5,705	6,085	4,718	2,772	5,037	9,991	7,926	5,144	7,330	7,564	7,628	3,179
Cash & Short-Term Investments	6,864	8,350	6,059	4,198	6,697	11,568	7,926	5,213	7,349	9,613	7,643	3,179
Receivables	4,790	4,660	4,669	4,663	4,587	4,420	4,388	4,781	5,095	4,913	4,741	5,055
Inventory	1,663	1,787	1,853	2,026	1,869	1,710	1,759	1,825	1,785	1,774	1,914	1,953
Goodwill	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314	8,314
Intangible Assets	27,151	26,454	23,428	22,832	20,545	19,948	19,354	18,567	17,969	16,978	16,381	14,033
Total Liabilities	40,132	39,376	38,837	35,382	36,135	39,749	37,356	36,130	37,077	36,405	32,847	37,618
Current Liabilities	11,945	11,280	13,016	10,780	11,724	12,004	12,343	11,189	12,297	11,813	9,475	11,020
Short-Term Debt	1,793	1,923	3,667	1,810	1,812	1,928	2,806	2,806	2,806	2,807	1,313	2,414
Accounts Payable	586	550	622	537	903	833	737	582	808	715	645	674
Long-Term Debt	23,189	23,189	21,527	21,540	21,437	24,896	22,146	22,140	22,135	22,129	20,861	23,832
Shareholders' Equity	22,313	22,833	17,539	18,281	18,474	19,330	19,162	19,675	21,540	22,702	23,515	11,828
Retained Earnings	16,002	16,304	10,656	11,165	11,073	11,497	10,931	11,325	12,825	13,730	14,131	2,200
Shares Outstanding	1,257	1,256	1,247	1,251	1,254	1,259	1,259	1,255	1,254	1,253	1,254	1,243

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings